These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Intragastric Administration of Lactobacillus plantarum and 2,2'-Dithiodipyridine-Inactivated Simian Immunodeficiency Virus (SIV) Does Not Protect Indian Rhesus Macaques from Intrarectal SIV Challenge or Reduce Virus Replication after Transmission. Carnathan DG; Mackel JJ; Sweat SL; Enemuo CA; Gebru EH; Dhadvai P; Gangadhara S; Hicks S; Vanderford TH; Amara RR; Esparza J; Lu W; Andrieu JM; Silvestri G J Virol; 2018 May; 92(10):. PubMed ID: 29491157 [TBL] [Abstract][Full Text] [Related]
31. Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques. Van Rompay KK; Marthas ML; Lifson JD; Berardi CJ; Vasquez GM; Agatep E; Dehqanzada ZA; Cundy KC; Bischofberger N; Pedersen NC AIDS Res Hum Retroviruses; 1998 Jun; 14(9):761-73. PubMed ID: 9643376 [TBL] [Abstract][Full Text] [Related]
32. Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV. Almond N; Berry N; Stebbings R; Preston M; Ham C; Page M; Ferguson D; Rose N; Li B; Mee ET; Hassall M; Stahl-Hennig C; Athanasopoulos T; Papagatsias T; Herath S; Benlahrech A; Dickson G; Meiser A; Patterson S J Virol; 2019 Nov; 93(21):. PubMed ID: 31413132 [TBL] [Abstract][Full Text] [Related]
33. Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers. Hessell AJ; Rakasz EG; Poignard P; Hangartner L; Landucci G; Forthal DN; Koff WC; Watkins DI; Burton DR PLoS Pathog; 2009 May; 5(5):e1000433. PubMed ID: 19436712 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of a candidate human immunodeficiency virus type 1 (HIV-1) vaccine in macaques: effect of vaccination with HIV-1 gp120 on subsequent challenge with heterologous simian immunodeficiency virus-HIV-1 chimeric virus. Stott EJ; Almond N; Kent K; Walker B; Hull R; Rose J; Silvera P; Sangster R; Corcoran T; Lines J; Silvera K; Luciw P; Murphy-Corb M; Momin P; Bruck C J Gen Virol; 1998 Mar; 79 ( Pt 3)():423-32. PubMed ID: 9519819 [TBL] [Abstract][Full Text] [Related]
35. Evidence for viral virulence as a predominant factor limiting human immunodeficiency virus vaccine efficacy. Mooij P; Bogers WM; Oostermeijer H; Koornstra W; Ten Haaft PJ; Verstrepen BE; Van Der Auwera G; Heeney JL J Virol; 2000 May; 74(9):4017-27. PubMed ID: 10756013 [TBL] [Abstract][Full Text] [Related]
36. Control of Heterologous Simian Immunodeficiency Virus SIV Singh S; RamÃrez-Salazar EG; Doueiri R; Valentin A; Rosati M; Hu X; Keele BF; Shen X; Tomaras GD; Ferrari G; LaBranche C; Montefiori DC; Das J; Alter G; Trinh HV; Hamlin C; Rao M; Dayton F; Bear J; Chowdhury B; Alicea C; Lifson JD; Broderick KE; Sardesai NY; Sivananthan SJ; Fox CB; Reed SG; Venzon DJ; Hirsch VM; Pavlakis GN; Felber BK J Virol; 2018 Aug; 92(15):. PubMed ID: 29793957 [TBL] [Abstract][Full Text] [Related]
37. A Prime/Boost Vaccine Regimen Alters the Rectal Microbiome and Impacts Immune Responses and Viremia Control Post-Simian Immunodeficiency Virus Infection in Male and Female Rhesus Macaques. Musich T; Thovarai V; Venzon DJ; Mohanram V; Tuero I; Miller-Novak LK; Helmold Hait S; Rahman MA; Hunegnaw R; Huiting E; Yuan W; O'hUigin C; Hoang T; Sui Y; LaBranche C; Montefiori D; Bear J; Rosati M; Bissa M; Berzofsky JA; Pavlakis GN; Felber BK; Franchini G; Robert-Guroff M J Virol; 2020 Nov; 94(24):. PubMed ID: 32967951 [TBL] [Abstract][Full Text] [Related]
38. Selective induction of cell-mediated immunity and protection of rhesus macaques from chronic SHIV(KU2) infection by prophylactic vaccination with a conserved HIV-1 envelope peptide-cocktail. Nehete PN; Nehete BP; Hill L; Manuri PR; Baladandayuthapani V; Feng L; Simmons J; Sastry KJ Virology; 2008 Jan; 370(1):130-41. PubMed ID: 17920095 [TBL] [Abstract][Full Text] [Related]
39. Vaccine-based, long-term, stable control of simian/human immunodeficiency virus 89.6PD replication in rhesus macaques. Yamamoto H; Kawada M; Tsukamoto T; Takeda A; Igarashi H; Miyazawa M; Naruse T; Yasunami M; Kimura A; Matano T J Gen Virol; 2007 Feb; 88(Pt 2):652-659. PubMed ID: 17251584 [TBL] [Abstract][Full Text] [Related]
40. Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particles. Willey RL; Byrum R; Piatak M; Kim YB; Cho MW; Rossio JL; Bess J; Igarashi T; Endo Y; Arthur LO; Lifson JD; Martin MA J Virol; 2003 Jan; 77(2):1163-74. PubMed ID: 12502833 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]